SCHEMBL6413110

SCHEMBL6413110

O=C(NCCCc1ccccc1)OC1=NOC2(CCN(S(=O)(=O)c3ccc(F)cc3)CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PKM P14618 2/20 0.42
TGM2 P21980 1/20 0.41
EPHX2 P34913 1/20 0.41
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
FKBP1A P62942 1/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2400977 0.85 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2PKMTGM2EPHX2
SCHEMBL6411660 0.84 PKM (0.51) ALDH1A1SMN1; SMN2PKMGAANPC1
SCHEMBL6415335 0.84 TSHR (0.44) ALDH1A1SMN1; SMN2GAALMNAMEN1
SCHEMBL6410349 0.83 NAMPT (0.49) ALDH1A1PKMGAAL3MBTL1LMNA
SCHEMBL6410674 0.82 KMT2A (0.52) ALDH1A1SMN1; SMN2L3MBTL1LMNAMEN1
SCHEMBL6410874 0.81 PKM (0.46) ALDH1A1SMN1; SMN2PKMGAAL3MBTL1
SCHEMBL6409957 0.80 KMT2A (0.45) ALDH1A1SMN1; SMN2GAAL3MBTL1MEN1
SCHEMBL6412990 0.80 CYP2C19 (0.41) ALDH1A1SMN1; SMN2GAALMNANPC1
SCHEMBL6413457 0.80 MEN1 (0.44) ALDH1A1PKMLMNACHRNB2CHRNB4
SCHEMBL6411131 0.78 MEN1 (0.46) ALDH1A1SMN1; SMN2GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed